- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00366808
Mechanical vs. Alcohol Separation of the Corneal Epithelium During Surface Ablation Refractive Procedures
A recent survey of trends among the members of the American Society of Cataract and Refractive Surgery determined that laser in situ keratomileusis (LASIK) is the leading surgical procedure for photorefractive corrections ranging from -0 to 3 diopters (D).1 The same survey, however, showed a clear trend of participating refractive surgeons toward surface ablation. Photorefractive keratectomy (PRK) was the first refractive surgery procedure approved and performed using the excimer laser. Several techniques of epithelial debridement have been tried with PRK-type surgery including mechanical debridement, laser transepithelial ablation, a rotating brush, and alcohol debridement.
The Amadeus II microkeratome (Advanced Medical Optics Inc, Irvine, CA, USA) used for the creation of a LASIK flap has an upgradeable platform that will allow the user to perform mechanical separation of the corneal epithelium before photorefractive treatments. With the use of this device, the corneal epithelium can be separated from the underlying stroma without previous preparation of the corneal surface with alcohol. The separated epithelial sheet can either be removed or replaced on the operated cornea after photoablation. This surgical procedure, which has been called Epi-LASIK, represents an advanced alternative surface ablation photorefractive procedure for the correction of ametropia. The purpose of this study is to evaluate the clinical visual outcomes, healing rates, and patient satisfaction when performing surface ablation procedures using mechanical vs. alcohol separation of the epithelium.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Magill Laser Center, Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject must be a candidate for surface ablation procedures in both eyes.
- ≥ 18 years of age or older.
- Myopia ≤ -6.00 D.
- Astigmatism ≤ - 3.00 D.
- Manifest refraction spherical equivalent (MRSE) of -6.00 D.
- Capable of wearing a bandage contact lens.
- Willing and able to comply with scheduled visits and other study procedures.
Exclusion Criteria:
- History of ocular pathology.
- Very large pupils (greater than 8mm diameter, infrared measurement).
- Thin corneas (preoperatively calculated minimal residual bed < 250 um).
- If patient fit into the group of the usual exclusionary criteria (e.g. irregular astigmatism, asymmetric astigmatism, unstable refraction - most of these patients would not typically be considered LASIK candidates under normal circumstances).
- History of previous refractive surgery.
- Corneal irregularities potentially affecting visual acuity: keratoconus, corneal dystrophy, corneal opacities.
- Participation in (or current participation) any investigational drug or device trial within the previous 30 days prior to the start date of this trial.
- Intraocular conventional surgery within the past three months or intraocular laser surgery within one month in the operated eye.
- Use of any systemic or topical drug known to interfere with visual performance.
- Pregnant or nursing mothers and females of childbearing potential not practicing a reliable and medically acceptable method of birth control
- Inability or unwillingness of subjects to give written informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Collaborators and Investigators
Investigators
- Principal Investigator: Kerry Solomon, MD, Medical University of South Carolina
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MRC-06-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratomileusis, Laser In Situ
-
AllerganCompleted
-
Food and Drug Administration (FDA)United States Department of Defense; National Eye Institute (NEI); United States...Completed
-
Food and Drug Administration (FDA)National Eye Institute (NEI)Completed
-
Taipei Nobel Eye ClinicCompleted
-
University of Texas Southwestern Medical CenterWithdrawn
-
Vissum, Instituto Oftalmológico de AlicanteCompletedDry Eye After LASIK-Laser in Situ Keratomileusis
-
University Hospital, BrestRecruitingDry Eye | Dry Eye After LASIK-Laser in Situ KeratomileusisFrance
-
University of MichiganCompletedLaser Hair Removal in Healthy SubjectsUnited States
-
Alexandria UniversityRecruitingChanges in Bacterial Count in Axilla After Laser Hair RemovalEgypt
-
Assiut UniversityUnknownFemtosecond Laser in Comparison to Moria Microkeratome in Creating Corneal Flaps
Clinical Trials on LASIK surgery
-
Kasr El Aini HospitalNot yet recruitingFS-LASIK Surgery Effect on Higher Order AberrationsEgypt
-
Food and Drug Administration (FDA)National Eye Institute (NEI)Completed
-
Tianjin Eye HospitalAlexandria University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and other collaboratorsUnknown
-
Assiut UniversityCompletedPatients With Myopic Spherical Equivalent up to -12 DioptersEgypt
-
Hoopes VisionAlcon ResearchRecruitingAstigmatism | MyopiaUnited States
-
Deb GrzybowskiCompleted
-
Alcon ResearchCompletedMyopia | HyperopiaUnited States
-
Edward E. MancheCompletedAstigmatism | Myopia | Quality of LifteUnited States